Walleye Capital LLC Vivos Therapeutics, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.71 - $5.9 $406,500 - $885,000	-150,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.83 - $9.67 $724,500 - $1.45 Million	150,000 New	150,000 $743,000
Q1 2021 May 17, 2021	SELL	$6.01 - $8.9 $447,745 - $663,050	-74,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.91 - $9.11 $440,295 - $678,695	74,500 New	74,500 $440,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $60.3M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.